86 related articles for article (PubMed ID: 6104674)
1. Separation of alkylaminonaphthylenesulfonyl peptides and amin acids by high-performance liquid chromatography. Methods for measuring melanotropin inhibiting factor breakdown.
Hui KS; Salschutz M; Davis BA; Lajtha A
J Chromatogr; 1980 May; 192(2):341-50. PubMed ID: 6104674
[TBL] [Abstract][Full Text] [Related]
2. Melanocyte-stimulating hormone release-inhibiting factor-1 (MIF-1) can be formed from Tyr-MIF-1 in brain mitochondria but not in brain homogenate.
Kastin AJ; Hahn K; Zadina JE; Banks WA; Hackler L
J Neurochem; 1995 Apr; 64(4):1855-9. PubMed ID: 7891114
[TBL] [Abstract][Full Text] [Related]
3. Degradation of melanotropin inhibiting factor by brain.
Hui KS; Cheng KP; Wong KH; Salschutz M; Lajtha A
J Neurochem; 1980 Aug; 35(2):471-8. PubMed ID: 6108995
[TBL] [Abstract][Full Text] [Related]
4. Sensitive determination of N-terminal prolyl peptides by high-performance liquid chromatography with laser-induced fluorescence detection.
Toyo'oka T; Ishibashi M; Terao T
J Chromatogr A; 1994 Feb; 661(1-2):105-12. PubMed ID: 8136900
[TBL] [Abstract][Full Text] [Related]
5. Regional differences in the metabolism of Tyr-MIF-1 and Tyr-W-MIF-1 by rat brain mitochondria.
Kastin AJ; Hahn K; Banks WA; Zadina JE
Biochem Pharmacol; 1998 Jan; 55(1):33-6. PubMed ID: 9413927
[TBL] [Abstract][Full Text] [Related]
6. Evidence for presence of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) in human brain cortex.
Horvath A; Kastin AJ
Int J Pept Protein Res; 1990 Sep; 36(3):281-4. PubMed ID: 1980671
[TBL] [Abstract][Full Text] [Related]
7. Isolation of tyrosine-melanocyte-stimulating hormone release-inhibiting factor 1 from bovine brain tissue.
Horvath A; Kastin AJ
J Biol Chem; 1989 Feb; 264(4):2175-9. PubMed ID: 2563371
[TBL] [Abstract][Full Text] [Related]
8. Endogenous peptide Tyr-Pro-Trp-Gly-NH2 (Tyr-W-MIF-1) is transported from the brain to the blood by peptide transport system-1.
Banks WA; Kastin AJ; Ehrensing CA
J Neurosci Res; 1993 Aug; 35(6):690-5. PubMed ID: 8105102
[TBL] [Abstract][Full Text] [Related]
9. Structure activity relationship studies with hypothalamic peptide hormones. I. Effect of melanotropin release inhibiting factor and analogs on tolerance to morphine in the rat.
Bhargava HN; Kim HS
J Pharmacol Exp Ther; 1982 Feb; 220(2):394-8. PubMed ID: 6120229
[TBL] [Abstract][Full Text] [Related]
10. Chromatographic separation of enantiomers of non-protein alpha-amino acids after derivatization with Marfey's reagent and its four variants.
Bhushan R; Kumar V; Tanwar S
Amino Acids; 2009 Mar; 36(3):571-9. PubMed ID: 18612776
[TBL] [Abstract][Full Text] [Related]
11. Mass spectrometric quantification of MIF-1 in mouse brain by multiple reaction monitoring.
Kheterpal I; Kastin AJ; Mollah S; Yu C; Hsuchou H; Pan W
Peptides; 2009 Jul; 30(7):1276-81. PubMed ID: 19540426
[TBL] [Abstract][Full Text] [Related]
12. Development of a radioimmunoassay for Pro-Leu-Gly-NH2 (PLG or MIF-I): evidence that PLG is not present in rat brain.
Manberg PJ; Youngblood WW; Kizer JS
Brain Res; 1982 Jun; 241(2):279-84. PubMed ID: 6125241
[TBL] [Abstract][Full Text] [Related]
13. Liquid chromatographic separation of some PTH-amino acids.
Bhushan R; Agarwal R
Biomed Chromatogr; 1998; 12(6):322-5. PubMed ID: 9861490
[TBL] [Abstract][Full Text] [Related]
14. Determination of the melanotropin-inhibiting factor analogue pareptide in urine by high-performance liquid chromatography.
Hui KS; Hui M; Cheng KP; Lajtha A; Boksay I; Fencik MU
J Chromatogr; 1981 Mar; 222(3):512-7. PubMed ID: 6112231
[No Abstract] [Full Text] [Related]
15. Use of L-prolyl-L-leucylglycinamide (MIF-1) for the high-performance liquid chromatographic determination of proline iminopeptidase activity in rat liver.
Hiraoka BY; Harada M
J Chromatogr; 1991 Jan; 563(1):142-6. PubMed ID: 1676401
[No Abstract] [Full Text] [Related]
16. H-Pro-[3H]Leu-Gly-NH2: uptake and metabolism in rat brain.
de Wildt D; Verhoef J; Witter A
J Neurochem; 1982 Jan; 38(1):67-74. PubMed ID: 6125567
[TBL] [Abstract][Full Text] [Related]
17. Peptide characterization with a sulfoethyl aspartamide column.
Crimmins DL; Gorka J; Thoma RS; Schwartz BD
J Chromatogr; 1988 Jun; 443():63-71. PubMed ID: 2844842
[TBL] [Abstract][Full Text] [Related]
18. Uptake, content, regulation of plasma concentrations, and binding of Tyr-MIF-1 by the adrenals.
Kastin AJ; Fabre L; Banks WA; Zadina JE
Neuroendocrinology; 1993 Mar; 57(3):541-9. PubMed ID: 8100620
[TBL] [Abstract][Full Text] [Related]
19. High-performance liquid chromatographic separation of peptides on a diol-Gly-Phe-Phe tripeptide-bonded phase.
Pinkerton TC; Koeplinger KA
J Chromatogr; 1988 Dec; 458():129-45. PubMed ID: 3235630
[TBL] [Abstract][Full Text] [Related]
20. Differential metabolism of Tyr-MIF-1 and MIF-1 in rat and human plasma.
Kastin AJ; Hahn K; Erchegyi J; Zadina JE; Hackler L; Palmgren M; Banks WA
Biochem Pharmacol; 1994 Feb; 47(4):699-709. PubMed ID: 7907473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
